Lorrca Oxygenscan as a biomarker for a gene-based approach for SCD treatment.
Dr. Vivien Sheehan (Baylor College) using the Lorrca Oxygenscan as a biomarker for a gene-based approach for SCD treatment.
Entries by Harold Schavemaker
EHA25 – 2020
Lorrca is included in hematological research and clinical discussions presented at the EHA25-2020. https://ehaweb.org/congress/eha25/virtual/
Interactieve ZOOM-meeting
RR Mechatronics organiseert op 19 juni 2020 in samenwerking met patientenverenigingen Oscar Nederland en SZB een interactief bezoek aan ons bedrijf.
RR Mechatronics at the ASH 2019
The American Society Hematology (ASH) Conference is world’s most comprehensive hematology event of the year. Also this year RR Mechatronics will be present, visit us at booth 665. At the ASH several Lorrca related papers will be presented: Rheological Assessments of Sickle Cell Patients Post Allogeneic Hematopoietic Cell Transplant A Novel Composition of Endogenous Metabolic […]
Very successful EHA Conference for RR Mechatronics’s Lorrca Team in Amsterdam
The European Hematology Association (EHA) Congress is world’s most comprehensive European Hematology event of the year. The 2019 edition was the 24th EHA Annual Meeting and was organized at our backdoor in Amsterdam. More than 11,000 hematology professionals and hundreds of exhibitors were present. Exhibitors included pharmaceutical companies, medical suppliers, publishers, non-profit organizations, clinical diagnostic […]
World Sickle Cell Awareness Day
On the 19th of June we celebrate World Sickle Cell Awareness Day. This day we raise the public awareness about the sickle cell disease, sickle cell patients and treatment methods for the disease. Sickle cell disease (SCD) is an inherited genetic abnormality of hemoglobin (the oxygen-carrying protein) in red blood cells. Sickle Cell Disease The […]
The Lorrca Osmoscan External Quality Control (EQC) pilot has been successfully completed!
Last month, eleven laboratories took part in a round trip of standardized material to test and compare the Lorrca measurements. Execution of the Osmoscan resulted in good corresponding measurements. It was also noted that there was no significant lot-to-lot variation of the reagent. These EQC will be performed annually from now on.
Today, 8 May, is International Thalassaemia Day
In time-honoured tradition, the Thalassaemia International Federation (TIF) is organising many diverse activities for the International Thalassaemia Day. Celebrated on the 8th May every year, these activities aim to sensitise the decision and policy makers and the health and patient committees at large on thalassaemia: How to prevent, treat and cure in a patient-centred manner. […]
Presentation of new article at the ILSH Conference, Vancouver 8-11 May 2019
On Friday May 10th the following article will be presented at the poster session: The Oxygenscan: a rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients / Minke Rab (1, 2), Brigitte van Oirschot(1), Jennifer Bos(1), Annet van Wesel(1), Maite Houwing(3), Marjon Cnossen(3), Roger Schutgens(2), Gerard Pasterkamp1, Marije Bartels(2), Eduard […]
Presentation of new article at the 13th Annual Sickle Cell Symposium
Conclusion of the article: The Lorrca with Oxygenscan can fully characterize RBC deformability under a range of oxygen concentrations. Key measurements – PoS, EImin, and EImax – were different between genotypes, and changed significantly with standard of care SCD treatments. We therefore conclude that these are useful biomarkers of clinical severity and treatment response, and […]
